Vedolizumab treatment across antiretroviral treatment interruption in chronic HIV infection: the HAVARTI protocol for a pilot dose-ranging clinical trial to assess safety, tolerance, immunological and virological activity.
Michaeline McGuintyJonathan B AngelCurtis L CooperJuthaporn CowanPaul A MacPhersonAshok KumarSanjay MurthyRichmond SyMichelle DennehyNancy TremblaySiddappa N ByrareddyD William CameronPublished in: BMJ open (2020)
ClinicalTrials.gov NCT03147859; https://clinicaltrials.gov/ct2/show/NCT03147859.